- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Compass Pathways Plc (CMPS)
Compass Pathways Plc stock price live, this page displays NASDAQ CMPS stock exchange data. View the CMPS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Compass Pathways Plc real time stock price chart below.
What Is the Compass Pathways Plc Stock Price Today?
The Compass Pathways Plc stock price today is 8.61.
What Is the Stock Symbol for Compass Pathways Plc?
The stock ticker symbol for Compass Pathways Plc is CMPS.
Is CMPS the Same as $CMPS?
$CMPS is a common way to refer to the Compass Pathways Plc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Compass Pathways Plc Trade On?
Compass Pathways Plc is listed and trades on the NASDAQ stock exchange.
Is Compass Pathways Plc a Good Stock to Buy?
Determining whether Compass Pathways Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Compass Pathways Plc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CMPS quote. (ISIN: US20451W1018)
What Is the Compass Pathways Plc Stock Price Today?
The Compass Pathways Plc stock price today is 8.61.
What Is the Stock Symbol for Compass Pathways Plc?
The stock ticker symbol for Compass Pathways Plc is CMPS.
Is CMPS the Same as $CMPS?
$CMPS is a common way to refer to the Compass Pathways Plc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Compass Pathways Plc Trade On?
Compass Pathways Plc is listed and trades on the NASDAQ stock exchange.
Is Compass Pathways Plc a Good Stock to Buy?
Determining whether Compass Pathways Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Compass Pathways Plc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CMPS quote. (ISIN: US20451W1018)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.99
8.68
52 wk Range
4.88
15.87
CMPS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.998.68
52 wk Range
4.8815.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CMPS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
23.31
Upside
+170.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Analyst Ratings
15 Buy
1 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23.31
(+170.76% Upside)
Compass Pathways Plc SWOT Analysis
Financial Forecast | Analyst price targets range from $12 to $60, with projections of peak revenues reaching $2.3 billion for COMP360 across global markets and indications |
Market Momentum | Explore the evolving landscape of psychedelic therapeutics and Compass Pathways' position at the forefront of a potentially transformative approach to mental health care |
Trial Tribulations | Delve into the challenges and opportunities of Compass Pathways' Phase III trials, including recruitment hurdles and the anticipated data release in Q4 2024 |
Psilocybin Pionee | Compass Pathways leads the charge in psychedelic therapeutics, developing COMP360 for treatment-resistant depression with a potential billion-dollar market |
Compass Pathways Plc Earnings Call Summary for Q3/2026
- COMPASS reported Q3 2026 loss of $0.31/share, beating estimates of $0.36/share; shares surged 10.58% to $9.30 in premarket trading.
- Company holds $444M cash, sufficient to fund operations through planned 2027 COMP360 launch and into 2028 without immediate financing needs.
- Rolling NDA submission for psilocybin treatment COMP360 to complete within two weeks; FDA priority voucher may enable 1-2 month review timeline.
- Management targets H1 2027 launch for treatment-resistant depression therapy; 90% of interventional psychiatrists indicated willingness to prescribe.
- Commercial infrastructure buildout underway with REMS preparation, specialty pharmacy reimbursement strategy, and CPT code transition expected in 12-18 months.
Last Updated: 11/03/2026, 08:58 AM
Read Full TranscriptCompass Pathways investor slides for Q3/2026
Last Update: Nov 03, 2026
See full investor slides
Earnings
Latest Release
Nov 03, 2026
EPS / Forecast
-0.31 / -0.36
Revenue / Forecast
-- / --
Compare CMPS to Peers and Sector
Metrics to compare | CMPS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCMPSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.5x | −1.6x | −0.2x | |
PEG Ratio | −0.24 | 0.02 | 0.00 | |
Price / Book | 8.4x | 2.2x | 2.6x | |
Price / LTM Sales | - | 3.3x | 2.8x | |
Upside (Analyst Target) | 170.8% | 175.6% | 60.9% | |
Fair Value Upside | Unlock | 27.1% | 9.5% | Unlock |
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Compass Pathways (CMPS) Stock Price Today?
The Compass Pathways stock price today is 8.61 USD.
What Stock Exchange Does Compass Pathways Trade On?
Compass Pathways is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Compass Pathways?
The stock symbol for Compass Pathways is "CMPS."
What Is the Compass Pathways Market Cap?
As of today, Compass Pathways market cap is 1.19B USD.
What Is Compass Pathways's Earnings Per Share (TTM)?
The Compass Pathways EPS (TTM) is -2.22.
When Is the Next Compass Pathways Earnings Date?
Compass Pathways will release its next earnings report on Mar 04, 2027.
From a Technical Analysis Perspective, Is CMPS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Compass Pathways Stock Split?
Compass Pathways has split 0 times.
How Many Employees Does Compass Pathways Have?
Compass Pathways has 156 employees.
What is the current trading status of Compass Pathways (CMPS)?
As of Nov 09, 2026, Compass Pathways (CMPS) is trading at a price of 8.61 USD, with a previous close of 8.61 USD. The stock has fluctuated within a day range of 7.99 USD to 8.68 USD, while its 52-week range spans from 4.88 USD to 15.87 USD.
What Is Compass Pathways (CMPS) Price Target According to Analysts?
The average 12-month price target for Compass Pathways is 23.31 USD, with a high estimate of 65 USD and a low estimate of 10 USD. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +170.76% Upside potential.
What Is the CMPS After Hours Price?
CMPS's last after hours stock price is 8.80 USD, the stock has decreased by 0.19, or 2.21%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.